Advertisement
GE Healthcare
GE Healthcare

The Scientist

» drug development and immunology

Most Recent

image: Poor Little Devils

Poor Little Devils

By | November 1, 2014

See the devastating infectious cancer that may drive the Tasmanian Devil to extinction.

0 Comments

image: Circadian Atlas Chronicles Gene Expression

Circadian Atlas Chronicles Gene Expression

By | October 27, 2014

Researchers have mapped the times of day when mouse genes are transcribed across 12 organs.

1 Comment

image: Ebola Update

Ebola Update

By | October 23, 2014

Vaccine testing could start soon; Spanish nurse declared free of virus; travelers from West Africa restricted to five US airports

3 Comments

image: Nurse Infected with Ebola in Spain

Nurse Infected with Ebola in Spain

By | October 6, 2014

The case marks the first person to contract the virus outside of West Africa.

0 Comments

image: Epigenetics of Trained Innate Immunity

Epigenetics of Trained Innate Immunity

By | September 25, 2014

Documenting the epigenetic landscape of human innate immune cells reveals pathways essential for training macrophages.

2 Comments

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: FDA to Address Female Sexual Dysfunction

FDA to Address Female Sexual Dysfunction

By | August 15, 2014

The federal agency will convene a two-day workshop in October to discuss the development of drugs to treat the issue.

0 Comments

image: Award-winning Chemist Dies

Award-winning Chemist Dies

By | July 14, 2014

Carlos Barbas III, a renowned organic chemist whose research helped in drug development, passed away at age 49. 

0 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
The Scientist